Zimmer Biomet Holdings Inc ZBH reported quarterly earnings of $1.93 per share, which beat the analyst consensus estimate of $1.91. This is a 0.52% increase over earnings of $1.92 per share from the same period last year.
The company reported quarterly sales of $1.989 billion, which beat the analyst consensus estimate of $1.98 billion. This is a 0.95% decrease over sales of $2.008 billion the same period last year.
"My level of confidence in our turnaround increases with every quarter," said Bryan Hanson, CEO of Zimmer Biomet. "Our team is focused, engaged and has positioned the company for offense in the second half of 2019. I'm truly excited by the momentum we are seeing and we have updated our guidance to reflect the progress we made in the first half of the year."
Zimmer Biomet shares were trading at $123.91 in Friday’s pre-market session. The stock has a 52-week high of $134.55 and a 52-week low of $96.99.
Related Links:
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.